Home - Products - Angiogenesis - EGFR - Dehydroabietic acid

Dehydroabietic acid

CAS No. 1740-19-8

Dehydroabietic acid( —— )

Catalog No. M18122 CAS No. 1740-19-8

Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	50	In Stock
10MG	87	In Stock
25MG	165	In Stock
50MG	248	In Stock
100MG	357	In Stock
500MG	845	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Dehydroabietic acid
Note

Research use only, not for human use.
Brief Description

Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.
Description

Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor. DAA is a useful food-derived compound for treating obesity-related diseases, by decreasing plasma glucose, insulin levels, plasma triglyceride (TG) , and hepatic TG levels. DAA derivatives displays anti-secretory and anti-pepsin effect in animal models.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

EGFR
Recptor

EBV
Research Area

Others-Field
Indication

——

Chemical Information

CAS Number

1740-19-8
Formula Weight

300.44
Molecular Formula

C20H28O2
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (332.85 mM)
SMILES

CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)C(=O)O)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

RTC-5

RTC-5 (TRC-382) is a phenothiazine compound that has been specifically enhanced for its potent anti-cancer properties.
SU5402

SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.
Icotinib

Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM.

Sign In Join Free